HIV-1 Vpr activates both canonical and noncanonical NF-κB pathway by enhancing the phosphorylation of IKKα/β

Virology. 2013 Apr 25;439(1):47-56. doi: 10.1016/j.virol.2013.01.020. Epub 2013 Feb 28.

Abstract

The human immunodeficiency virus type I (HIV-1) Vpr plays an essential role in viral replication. A number of studies have reported that Vpr modulates the nuclear factor-κB (NF-κB) pathway. Yet, the reported effects of Vpr on NF-κB signaling are controversial. In this study, we investigate the interplay between Vpr and NF-κB pathway. We discover that HIV-1 infection elevates the phosphorylation of IκBα and p100, and that this increase is greatly reduced when a Vpr-negative HIV-1 is used for infection. Our data further show that Vpr regulates the activity of IKKα/β through interactions. In addition, Vpr modulates the phosphorylation of p65 and p100, suggesting that Vpr activates both canonical and noncanonical NF-κB pathway. Knock down of endogenous IKKα/β result in a decrease in Vpr-mediated NF-κB and HIV-1 LTR activation. Given that Vpr is present in HIV-1 particles, our data suggest that Vpr activates the NF-κB pathway immediately after HIV-1 entry.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line
  • Endonucleases
  • HIV-1 / immunology
  • HIV-1 / physiology*
  • Humans
  • I-kappa B Kinase / immunology
  • I-kappa B Kinase / metabolism*
  • NF-kappa B / immunology
  • NF-kappa B / metabolism*
  • Nuclear Proteins / metabolism
  • Phosphorylation
  • Protein Interaction Mapping
  • Protein Processing, Post-Translational*
  • Signal Transduction
  • Virus Replication*
  • vpr Gene Products, Human Immunodeficiency Virus / immunology
  • vpr Gene Products, Human Immunodeficiency Virus / metabolism*

Substances

  • NF-kappa B
  • Nuclear Proteins
  • vpr Gene Products, Human Immunodeficiency Virus
  • vpr protein, Human immunodeficiency virus 1
  • I-kappa B Kinase
  • Endonucleases
  • SND1 protein, human